Hospital partnership improves follow up scans, decreases long term risk after aortic repair

Surveillance imaging was associated with a reduced death risk

10:05 AM

Author | Noah Fromson

A radiologist talks with a CT scan patient while in the control room.
Getty Images

Through a statewide partnership, hospitals in Michigan drastically increased the number of patients who receive follow up imaging after undergoing aortic aneurysm repair, according to a recent study.

The rate of imaging in the year following endovascular aneurysm repair, or EVAR, improved from nearly 28% in 2017 to just below 80% in 2023.

Patients who participated in surveillance imaging had a nearly 60% decrease in the likelihood of dying within one year of surgery, after controlling for other comorbidities.

The results are published in Circulation: Population Health and Outcomes.

“EVAR is now more common that open surgery, yet as many as 57% of patients were missing essential follow up imaging,” said first author Frank M. Davis, M.D., assistant professor of surgery at University of Michigan Medical School and vascular surgeon at the U-M Health Frankel Cardiovascular Center.

“Through this partnership, we saw sweeping improvements in surveillance imaging that will allow clinicians to detect early problems that can lead to device failure or future, threatening complications such as aortic rupture.”

Current guidelines from the Society for Vascular Surgeons recommend annual lifelong surveillance after EVAR with CT scanning or ultrasound.

More than 30 hospitals participated in the improvement initiative that offered financial insurance reimbursement for encouraging surveillance imaging in the year following endovascular repair of abdominal aortic aneurysm.

The initiative formed through the Blue Cross Blue Shield of Michigan Cardiovascular Consortium, or BMC2, registry.

The consortium, housed at Michigan Medicine, is comprised of hospitals across the state of Michigan that use data they collect to inform quality projects, and improve care and patient outcomes.

Before the study, the rate of EVAR surveillance imaging just one year after the operation varied in Michigan from 3.7% at smaller hospitals to 62.5% at larger facilities.

The effort led to improvement across Michigan hospitals and was not driven by high-performing health care systems.

By 2023, 95% of participating hospitals had EVAR surveillance rates above 60%.

“The long term success of a surveillance program like this depends on identifying processes at each participating hospital that can be built into routine practice, making them easier for health care teams to sustain,” said senior author Nicholas Osborne, M.D., M.S., Ramon Bergeur M.D., Ph.D., Research Professor of Vascular Surgery at U-M Medical School and director of BMC2.

Each year, around 200,000 Americans are affected by abdominal aortic aneurysm.

Around 14% of patients who have EVAR require a second procedure within four to five years and less than 2% experience late aortic rupture as a complication.

Patients who received surveillance imaging during the study period had a higher number of repeat interventions than those who did not get imaging.

Their mortality rate, however, was significantly lower.

Past studies have mixed results as to whether follow up imaging is associated with reduced risk of death after endovascular repair.

Researchers say future studies using BMC2 data will assess mortality risk after five and 10 years of surveillance.

“This study demonstrates the importance of BMC2, as implementation of quality programs across the state of Michigan care lead to substantial improvement in care for patients including those who have aortic surgery,” Davis said.

Additional authors: Jeremy Albright, Ph.D., and Brennan Callow, both of University of Michigan, Loay Kobbani, M.D., and Tamer Boules, M.D., of Henry Ford Health System, Hue Thai, M.D., of Trinity Health Ann Arbor, and Nicolas Mouawad, M.D., of McLaren Health System.

Funding/disclosures: Davis is supported by a VA Career Development grant (IK2BX006562)

Support for BMC2 is provided by Blue Cross Blue Shield of Michigan and Blue Care Network as part of the BCBSM Value Partnerships program.

Although Blue Cross Blue Shield of Michigan and BMC2 work collaboratively, the opinions, beliefs, and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.

Further, BCBSM does not have access to BMC2 data, and all patient episodes occurring at engaged hospitals are included in the data registries, regardless of payer.

Paper cited: “Association between Creation of an Endovascular Aortic Aneurysm Surveillance Program and One-Year Follow-Up and Mortality in the State of Michigan, USA,” Circulation: Population Health and Outcomes. DOI: 10.1161/CIRCOUTCOMES.125.012472

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week.

Sign up for the Health Lab Podcast. Add us wherever you listen to your favorite shows.  


More Articles About:

All Research Topics Vascular Surgery Frankel Cardiovascular Center Cardiovascular: Diseases & Conditions Cardiovascular: Treatment & Surgery Aortic Aneurysm Aortic Disease Computed Tomography Scan (CT) Radiology & Diagnostic Imaging Ultrasound
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

Frank Davis profile photo

Frank M Davis, MD

Assistant Professor

portrait of Nicholas Osborne

Nicholas Osborne, MD, MS, FACS, RPVI

Associate Professor

Related

heart organ yellow blue
Health Lab

Around 10% of deaths from coronary stenting, balloon angioplasty are preventable

Around 10% of all deaths following percutaneous coronary intervention are potentially preventable, a study led by Michigan Medicine finds.
up close doctor in hospital with cardiology close up scans on monitors
Health Lab

Researchers find significant differences in care of life threatening shock after heart attack

A study finds most hospitals don’t see many cardiogenic shock patients. When they do, providers often do not have a standardized way of treating them.

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

layers of skin pink to yellow
Health Lab

Study outlines a new framework for direct cell reprogramming

In a new paper published in the journal iScience, Lindsey Muir, Ph.D. and her lab at Michigan Medicine propose a framework for direct cell reprogramming.
Minding memory above a microphone on a blue background
Minding Memory

Is the United States Lagging Behind Europe in Memory Improvement?

In this episode, Lauren & Matt speak with Neil Mehta, PhD who is the associate dean for research and a professor in the Department of Epidemiology at the University of Texas Medical Branch in Galveston. Dr. Mehta’s research focuses on US life expectancy trends, the effects of obesity on disability and mortality, the sources of socioeconomic status disparities in mortality, and patterns of health in the United States and Europe. Dr. Mehta talks about a recent manuscript from the NIA-funded TRENDS study called “Trends in Memory Function and Memory Impairment Among Older Adults in the United States and Europe, 1996 to 2018.”, which looks at data from several sources to compare trends in memory function across 13 different countries.
people crowd aerial network connections
Health Lab

New insight into how lipodystrophy can affect overall health

What is lipodystrophy? Expert insights on partial vs. generalized fat loss, health complications, leptin therapy, and emerging clinical research.
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast

PMOS is the New PCOS

What the shift from PCOS to PMOS means for your fertility journey.
red blood cells going through clear tube red background
Health Lab

FDA-approved drug offers hope for patients with polycythemia vera, a rare bone marrow disorder

FDA-approved rusfertide offers new hope for polycythemia vera patients by reducing phlebotomy dependence, easing symptoms, and improving daily life.
cells close up blue and green background microscope
Health Lab

Engineered nanoparticles sensitize gliomas to radiotherapy

University of Michigan researchers discovered a new pathway that sensitizes mIDH1 gliomas to radiation in human and mouse mIDH1 glioma cells and mouse models, paving the way for phase 1 clinical trials in humans